Different Dietary Approaches, Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease: A Literature Review

被引:15
|
作者
Torres-Pena, Jose D. [1 ,2 ]
Arenas-de Larriva, Antonio P. [1 ,2 ]
Alcala-Diaz, Juan F. [1 ,2 ]
Lopez-Miranda, Jose [1 ,2 ]
Delgado-Lista, Javier [1 ,2 ]
机构
[1] Univ Cordoba, Reina Sofia Univ Hosp, Maimonides Biomed Res Inst Cordoba IMIBIC, Dept Internal Med,Lipids & Atherosclerosis Unit, Ave Menendez Pidal S-N, Cordoba 14004, Spain
[2] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid 28029, Spain
关键词
non-alcoholic fatty liver disease; Mediterranean diet; intermittent fasting; low-fat diet; ketogenic diet; low-carbohydrate diet; DASH diet; cardiovascular disease; IMPROVES ENDOTHELIAL FUNCTION; MEDITERRANEAN DIET; WEIGHT-LOSS; HEPATIC STEATOSIS; GENETIC-FACTORS; EATING HABITS; DASH DIET; ADHERENCE; RISK; ASSOCIATION;
D O I
10.3390/nu15061483
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is the first cause of chronic liver disease and is also associated with other harmful entities such as obesity, metabolic syndrome, dyslipidemia, and diabetes. NAFLD is a significant public health concern worldwide, impacting individuals of all ages, and its prevalence is projected to increase in the near future due to its connection with obesity. Intrinsic (genetics) and external (lifestyle) factors may also modulate NAFLD, and, in turn, may partly explain the observed relationship between NAFLD and cardiovascular disease (CVD). Although many drugs are been tested to treat NAFLD, to date, no drug has indication to specifically treat this disorder. Thus, the current management of NAFLD relies on lifestyle modifications and specifically on weight loss, physical activity, and the intake of a healthy diet. In the present narrative review, we will discuss the effects of certain dietary patterns on NAFLD incidence and progression.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences
    Del Ben, Maria
    Baratta, Francesco
    Polimeni, Licia
    Angelico, Francesco
    INTERNAL AND EMERGENCY MEDICINE, 2012, 7 : S291 - S296
  • [42] Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease
    Eslamparast, Tannaz
    Tandon, Puneeta
    Raman, Maitreyi
    NUTRIENTS, 2017, 9 (08)
  • [43] Increased prevalence of cardiovascular disease in Type 1 diabetic patients with non-alcoholic fatty liver disease
    Targher, G.
    Pichiri, I.
    Zoppini, G.
    Trombetta, M.
    Bonora, E.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (05) : 535 - 540
  • [44] The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
    Yu, Siyu
    Li, Chunlin
    Ji, Guang
    Zhang, Li
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [45] Non-pharmacological interventions in non-alcoholic fatty liver disease patients
    Ratziu, Vlad
    LIVER INTERNATIONAL, 2017, 37 : 90 - 96
  • [46] The epidemiology of non-alcoholic fatty liver disease
    Bellentani, Stefano
    LIVER INTERNATIONAL, 2017, 37 : 81 - 84
  • [47] Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet
    Abenavoli, Ludovico
    Milic, Natasa
    Peta, Valentina
    Alfieri, Francesco
    De Lorenzo, Antonino
    Bellentani, Stefano
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (45) : 16831 - 16840
  • [48] Brain involvement in non-alcoholic fatty liver disease (NAFLD): A systematic review
    Lombardi, Rosa
    Fargion, Silvia
    Fracanzani, Anna Ludovica
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (09) : 1214 - 1222
  • [49] The Role of Non-alcoholic Fatty Liver Disease in Cardiovascular Disease
    Francque, Sven M.
    EUROPEAN CARDIOLOGY REVIEW, 2014, 9 (01) : 10 - 15
  • [50] Non-alcoholic fatty liver disease and lipotoxicity
    Wasilewska, Natalia
    Lebensztejn, Dariusz Marek
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 7 (01) : 1 - 6